HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Je Chen Selected Research

Hypoxia (Hypoxemia)

1/2018Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.
2/2013Intravenous HOE-642 reduces brain edema and Na uptake in the rat permanent middle cerebral artery occlusion model of stroke: evidence for participation of the blood-brain barrier Na/H exchanger.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Je Chen Research Topics

Disease

5Stroke (Strokes)
10/2021 - 12/2011
5Ischemic Stroke
01/2019 - 12/2011
4Infarction (Infarctions)
01/2018 - 12/2011
3Brain Edema (Cerebral Edema)
01/2019 - 02/2013
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2016 - 12/2011
2Inflammation (Inflammations)
11/2020 - 01/2018
2Hypoxia (Hypoxemia)
01/2018 - 02/2013
2Ischemia
12/2016 - 12/2011
2Edema (Dropsy)
01/2015 - 02/2013
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021
1Seizures (Absence Seizure)
01/2020
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2020
1Hyperglycemia
01/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2018
1Neuroinflammatory Diseases
12/2016
1Pain (Aches)
01/2015
1Acute Pain
01/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2014
1Cardiomyopathies (Cardiomyopathy)
03/2014
1Brain Ischemia (Cerebral Ischemia)
02/2013
1Hyperplasia
01/2013
1Fibrosis (Cirrhosis)
01/2013

Drug/Important Bio-Agent (IBA)

4TRAM 34IBA
12/2016 - 12/2011
2cariporideIBA
01/2019 - 02/2013
2Bumetanide (Bumex)FDA LinkGeneric
01/2019 - 02/2013
1Tobacco Smoke Pollution (Passive Smoking)IBA
01/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2021
1Purinergic P2X4 ReceptorsIBA
11/2020
1tetramethylenedisulfotetramine (DSTA)IBA
01/2020
1PicrotoxinIBA
01/2020
1RodenticidesIBA
01/2020
1CME-Carbodiimide (CMEC)IBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1Minocycline (Cyclops)FDA LinkGeneric
01/2018
1Immunologic Factors (Immunomodulators)IBA
01/2018
1Interleukin-10 (Interleukin 10)IBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1Nerve Growth Factor (NGF)IBA
01/2018
1Kv1.3 Potassium ChannelIBA
01/2018
1Potassium Channels (Potassium Channel)IBA
12/2016
1Troponin CIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2015
1Formaldehyde (Formol)FDA Link
01/2015
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
03/2014
1Sodium-Hydrogen ExchangersIBA
02/2013
1Arginine Vasopressin (Argipressin)IBA
02/2013
1Sodium-Potassium-Chloride SymportersIBA
02/2013
1CollagenIBA
01/2013
1Phenobarbital (Luminal)FDA Link
01/2013
1CalciumIBA
12/2011
1Eosine Yellowish-(YS) (Eosin)IBA
12/2011
1Hematoxylin (Haematoxylon)IBA
12/2011

Therapy/Procedure

1Therapeutics
10/2021
1Ligation
01/2015
1Immunotherapy
12/2014
1Intravenous Administration
02/2013
1Transplantation
01/2013